Uncovering insights on GLP-1 and GIP/GLP-1 medications

In collaboration with our partners at Sermo, our Advanced Data Science and Artificial Intelligence solutions played a crucial role in uncovering previously unseen intelligence about GLP-1 and GIP/GLP-1. This report is designed to comprehend challenges, perceptions, attitudes, and usage surrounding GLP-1 and GIP/GLP-1 medications among patients and physicians, reflecting not just our efforts but the collaborative success in providing valuable healthcare intelligence to our partners.

Gain exclusive access to this report and uncover previously unseen insights into the impact of GLP-1 and GIP/GLP-1 drugs in the type 2 diabetes space.

  • Gain insight into how GLP-1 and GIP/GLP-1 drugs have revolutionized the type 2 diabetes space.
  • Explore how physicians and patients alike are talking, thinking, and reacting to GLP-1 and GIP/GLP-1 medications.
  • Deep dive into learnings about specific medications like semaglutide and tirzepatide both from the physician and patient perspective.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Tern plc

    More articles like this

    Tern plc

    Top 10 IoT trends predicted by Tern for 2024

    Here are Tern’s predictions for the top ten IoT trends we’ll see this year: 1. Continued growth in the number of connected devices It hardly requires a crystal ball to predict that the number of connected

    Tern plc

    Device Authority secures $7M funding for Enterprise IoT security

    Device Authority, a global leader in Identity and Access Management for Enterprise IoT ecosystems, announced $7M in Series A funding from Ten Eleven Ventures, a global venture capital firm specializing in cybersecurity. The investment follows Device Authority’s prestigious Microsoft

    Tern plc

    How Artificial Intelligence is reshaping healthcare

    2023 was a big year for artificial intelligence (AI). The launch of Chat-GPT-4, Microsoft Copilot, Google Bard and Amazon Q has raised awareness of the potential of AI solutions across the board. In the healthcare sector, the

    Tern plc

    Is your connected device secure and FDA compliant?

    As a medical device company, are you familiar with an FDA regulation called section 524b? What is Section 524b? On March 30th, 2023 an act was signed into law that contained a section on contained a

    Tern plc

    Tern supporting investee secured for Device Authority

    Tern recently took part in an interview with DirectorsTalk following the announcement in late December that portfolio company Device Authority had received a US$7m strategic investment from Ten Eleven, a global leader in cyber security with